PRDX1 and breast carcinoma: In breast cancer cells, SIRT2 could stop the peroxiredoxin-1 activity, increase the responsiveness of breast cancer cells to reactive oxygen species stimulated DNA damage and so encourage the apoptosis of cancer cells [25].